id	sid	eid	entity	type
dti-2024	1	1	2007	DATE
dti-2024	1	2	2 61–69 61	CARDINAL
dti-2024	1	3	maria de nazaré c. soeiro	PERSON
dti-2024	2	1	21 2598-4331	CARDINAL
dti-2024	2	2	55 21 2260-4434	TIME
dti-2024	3	1	http://www.la-press.com/copyright.htm	DATE
dti-2024	3	2	db569 elen m. de souza	PERSON
dti-2024	3	3	gabriel m. oliveira	PERSON
dti-2024	3	4	maria de nazaré c. soeiro	PERSON
dti-2024	4	1	dubc	PERSON
dti-2024	4	2	instituto oswaldo cruz	PERSON
dti-2024	4	3	fiocruz	ORG
dti-2024	4	4	rio de janeiro	GPE
dti-2024	4	5	rj	GPE
dti-2024	4	6	brasil.	PERSON
dti-2024	9	1	swiss	NORP
dti-2024	9	2	ecg	ORG
dti-2024	10	1	ecg	ORG
dti-2024	12	1	ecg	PRODUCT
dti-2024	13	1	ecg profi le	LAW
dti-2024	13	2	cd8+	ORG
dti-2024	14	1	infl ammation	ORG
dti-2024	15	1	trypanosoma cruzi	PERSON
dti-2024	15	2	over 16–18 million	CARDINAL
dti-2024	15	3	central america	LOC
dti-2024	15	4	50,000	CARDINAL
dti-2024	15	5	2002	DATE
dti-2024	16	1	two	CARDINAL
dti-2024	16	2	about one-third	CARDINAL
dti-2024	16	3	years or decades	DATE
dti-2024	16	4	2006	DATE
dti-2024	17	1	about 25% to 30%	PERCENT
dti-2024	17	2	1999	DATE
dti-2024	17	3	salles et al	LOC
dti-2024	17	4	2003	DATE
dti-2024	18	1	2004	DATE
dti-2024	18	2	petkova et al.	PERSON
dti-2024	18	3	2001	DATE
dti-2024	18	4	2003	DATE
dti-2024	19	1	ecg	ORG
dti-2024	19	2	maguire et al	PERSON
dti-2024	19	3	1987	DATE
dti-2024	20	1	ecg	PRODUCT
dti-2024	20	2	2003	DATE
dti-2024	20	3	garcia et al	PERSON
dti-2024	20	4	2005	DATE
dti-2024	21	1	ecg	ORG
dti-2024	21	2	rocha et al	PERSON
dti-2024	21	3	2003	DATE
dti-2024	22	1	100%	PERCENT
dti-2024	22	2	16 years	DATE
dti-2024	22	3	62	CARDINAL
dti-2024	22	4	de souza	PERSON
dti-2024	22	5	2007	DATE
dti-2024	22	6	2	CARDINAL
dti-2024	22	7	60%	PERCENT
dti-2024	22	8	4 years	DATE
dti-2024	22	9	2005	DATE
dti-2024	23	1	roche	ORG
dti-2024	23	2	coura	GPE
dti-2024	23	3	de castro	PERSON
dti-2024	23	4	2002	DATE
dti-2024	25	1	soeiro et al.	LOC
dti-2024	25	2	2005	DATE
dti-2024	25	3	wilson et al.	PERSON
dti-2024	25	4	2005	DATE
dti-2024	25	5	2006	DATE
dti-2024	26	1	2004	DATE
dti-2024	28	1	ecg	ORG
dti-2024	28	2	2003, 2005	DATE
dti-2024	28	3	zaidenberg et al	PERSON
dti-2024	28	4	2006	DATE
dti-2024	29	1	1982	DATE
dti-2024	30	1	oswaldo cruz	PERSON
dti-2024	30	2	brazil	GPE
dti-2024	31	1	8	CARDINAL
dti-2024	31	2	12/12	CARDINAL
dti-2024	33	1	i.p.	GPE
dti-2024	34	1	104	CARDINAL
dti-2024	35	1	3	CARDINAL
dti-2024	35	2	4	CARDINAL
dti-2024	35	3	the fiocruz committee of ethics	ORG
dti-2024	36	1	20 mg/kg	QUANTITY
dti-2024	37	1	at least 6	CARDINAL
dti-2024	37	2	the 21st	DATE
dti-2024	38	1	one-year	DATE
dti-2024	39	1	2002	DATE
dti-2024	40	1	200 mg	QUANTITY
dti-2024	40	2	0.1 ml	QUANTITY
dti-2024	40	3	i.p.	GPE
dti-2024	40	4	20 mg/kg	QUANTITY
dti-2024	40	5	3	CARDINAL
dti-2024	40	6	10 consecutive days	DATE
dti-2024	41	1	0.1ml	CARDINAL
dti-2024	41	2	daily	DATE
dti-2024	41	3	10 mm	QUANTITY
dti-2024	41	4	0.015	CARDINAL
dti-2024	41	5	7.4	CARDINAL
dti-2024	41	6	pbs	ORG
dti-2024	42	1	parasitaemia	PERSON
dti-2024	42	2	5	CARDINAL
dti-2024	42	3	de souza et al	PERSON
dti-2024	43	1	30	CARDINAL
dti-2024	43	2	de souza et al	PERSON
dti-2024	43	3	2006a	DATE
dti-2024	44	1	8	CARDINAL
dti-2024	44	2	15	DATE
dti-2024	44	3	one year	DATE
dti-2024	44	4	pbs	ORG
dti-2024	44	5	fi xed	GPE
dti-2024	44	6	10%	PERCENT
dti-2024	45	1	3 µm	DATE
dti-2024	45	2	hematoxylin	PERSON
dti-2024	46	1	more than 10	CARDINAL
dti-2024	46	2	at least 30	CARDINAL
dti-2024	46	3	40x	DATE
dti-2024	47	1	63	CARDINAL
dti-2024	47	2	2007	DATE
dti-2024	47	3	2	CARDINAL
dti-2024	47	4	infl	ORG
dti-2024	47	5	infi	NORP
dti-2024	47	6	at least three	CARDINAL
dti-2024	47	7	three	CARDINAL
dti-2024	48	1	three	CARDINAL
dti-2024	48	2	sacrifi ced	PERSON
dti-2024	48	3	infl	ORG
dti-2024	48	4	15	CARDINAL
dti-2024	48	5	de souza et al	PERSON
dti-2024	48	6	2006a	DATE
dti-2024	48	7	2004	DATE
dti-2024	49	1	briefl	PERSON
dti-2024	50	1	1 to 2 mm	QUANTITY
dti-2024	50	2	seven	CARDINAL
dti-2024	50	3	0.2%	PERCENT
dti-2024	51	1	pbs	ORG
dti-2024	51	2	fi xed	GPE
dti-2024	51	3	20 min	DATE
dti-2024	51	4	1%	PERCENT
dti-2024	51	5	san diego	GPE
dti-2024	52	1	pharmingen/bd biosciences	ORG
dti-2024	53	1	10,000	CARDINAL
dti-2024	53	2	becton dickinson	PERSON
dti-2024	53	3	san jose	GPE
dti-2024	54	1	joseph trotter	PERSON
dti-2024	54	2	scripps research institute	ORG
dti-2024	54	3	san diego	GPE
dti-2024	55	1	ecg	ORG
dti-2024	55	2	8, 15	DATE
dti-2024	55	3	1 year	DATE
dti-2024	56	1	t. cruzi-infected	PERSON
dti-2024	56	2	garcia et al	PERSON
dti-2024	56	3	2005	DATE
dti-2024	56	4	zeidenberg et al.	PERSON
dti-2024	56	5	2006	DATE
dti-2024	57	1	briefl y	PERSON
dti-2024	57	2	20 mg/kg	QUANTITY
dti-2024	57	3	i.p.	GPE
dti-2024	57	4	fi xed	GPE
dti-2024	57	5	eight	CARDINAL
dti-2024	57	6	18	CARDINAL
dti-2024	57	7	two	CARDINAL
dti-2024	58	1	2	CARDINAL
dti-2024	59	1	bio	PERSON
dti-2024	59	2	united kingdom	GPE
dti-2024	59	3	between 0.1 and 100	CARDINAL
dti-2024	59	4	16s	CARDINAL
dti-2024	60	1	16	CARDINAL
dti-2024	60	2	4	CARDINAL
dti-2024	61	1	ecg	PRODUCT
dti-2024	61	2	1.2	CARDINAL
dti-2024	62	1	ecg	ORG
dti-2024	62	2	bpm	ORG
dti-2024	62	3	pq	PERSON
dti-2024	62	4	qrs	PERSON
dti-2024	63	1	anova	ORG
dti-2024	64	1	2–4	CARDINAL
dti-2024	65	1	1	CARDINAL
dti-2024	65	2	ic50	ORG
dti-2024	65	3	de souza et al	PERSON
dti-2024	65	4	2004	DATE
dti-2024	66	1	2006a	DATE
dti-2024	67	1	2006a	DATE
dti-2024	68	1	confi rmed	ORG
dti-2024	69	1	2a	CARDINAL
dti-2024	70	1	95%	PERCENT
dti-2024	70	2	15th	ORDINAL
dti-2024	70	3	2b	CARDINAL
dti-2024	70	4	2b	CARDINAL
dti-2024	71	1	40%	PERCENT
dti-2024	72	1	2e	CARDINAL
dti-2024	73	1	2d	DATE
dti-2024	74	1	15th	ORDINAL
dti-2024	74	2	infl	ORG
dti-2024	74	3	de souza	PERSON
dti-2024	74	4	2007	DATE
dti-2024	74	5	2	CARDINAL
dti-2024	74	6	2006a	DATE
dti-2024	75	1	2c	CARDINAL
dti-2024	77	1	2	CARDINAL
dti-2024	77	2	infl	ORG
dti-2024	78	1	2	CARDINAL
dti-2024	79	1	3a	CARDINAL
dti-2024	80	1	8th	ORDINAL
dti-2024	81	1	3a	CARDINAL
dti-2024	82	1	15 and 21 dpi	PERCENT
dti-2024	82	2	ecg	ORG
dti-2024	83	1	3a	CARDINAL
dti-2024	84	1	630	CARDINAL
dti-2024	84	2	496	CARDINAL
dti-2024	84	3	501	CARDINAL
dti-2024	85	1	3a	CARDINAL
dti-2024	86	1	ecg	ORG
dti-2024	86	2	fig	ORG
dti-2024	87	1	3a	CARDINAL
dti-2024	88	1	40%	PERCENT
dti-2024	89	1	3e	CARDINAL
dti-2024	92	1	ecg	PRODUCT
dti-2024	92	2	ecg	PRODUCT
dti-2024	93	1	4a	CARDINAL
dti-2024	94	1	coura	GPE
dti-2024	94	2	de castro	PERSON
dti-2024	94	3	2002	DATE
dti-2024	95	1	soeiro et al. 2005	LOC
dti-2024	96	1	2004	DATE
dti-2024	97	1	2003	DATE
dti-2024	97	2	1	CARDINAL
dti-2024	99	1	65	CARDINAL
dti-2024	99	2	2007	DATE
dti-2024	99	3	2	CARDINAL
dti-2024	99	4	2	CARDINAL
dti-2024	99	5	104	CARDINAL
dti-2024	99	6	3 to 12	PERCENT
dti-2024	99	7	20 mg/kg	QUANTITY
dti-2024	99	8	15th	ORDINAL
dti-2024	99	9	fl ow cytometry analysis	ORG
dti-2024	100	1	the lymphocyte gate	FAC
dti-2024	100	2	cd8+	ORG
dti-2024	100	3	fsc × ssc	ORG
dti-2024	100	4	15th	ORDINAL
dti-2024	106	1	66	CARDINAL
dti-2024	106	2	de souza	PERSON
dti-2024	106	3	2007	DATE
dti-2024	106	4	2	CARDINAL
dti-2024	106	5	3	CARDINAL
dti-2024	106	6	pq	PERSON
dti-2024	106	7	qrs	PERSON
dti-2024	106	8	8°	QUANTITY
dti-2024	106	9	15°	QUANTITY
dti-2024	106	10	21°	QUANTITY
dti-2024	106	11	8°dpi	QUANTITY
dti-2024	106	12	15°dpi	QUANTITY
dti-2024	106	13	21°dpi	QUANTITY
dti-2024	107	1	30	CARDINAL
dti-2024	109	1	2	CARDINAL
dti-2024	109	2	2	CARDINAL
dti-2024	109	3	2	CARDINAL
dti-2024	109	4	100	CARDINAL
dti-2024	109	5	600 800	CARDINAL
dti-2024	109	6	2	CARDINAL
dti-2024	109	7	0 2	CARDINAL
dti-2024	109	8	2	CARDINAL
dti-2024	109	9	2	CARDINAL
dti-2024	109	10	100	CARDINAL
dti-2024	110	1	200	CARDINAL
dti-2024	110	2	0	CARDINAL
dti-2024	110	3	8 days	DATE
dti-2024	110	4	15 days	DATE
dti-2024	111	1	21 days	DATE
dti-2024	112	1	100	CARDINAL
dti-2024	112	2	6 12	DATE
dti-2024	112	3	24 30 dpi %	PERCENT
dti-2024	112	4	67	CARDINAL
dti-2024	112	5	2007	DATE
dti-2024	113	1	2	CARDINAL
dti-2024	113	2	2	CARDINAL
dti-2024	113	3	2	CARDINAL
dti-2024	113	4	2	CARDINAL
dti-2024	113	5	100	CARDINAL
dti-2024	113	6	200	CARDINAL
dti-2024	113	7	1 year	DATE
dti-2024	113	8	4	CARDINAL
dti-2024	113	9	one year	DATE
dti-2024	113	10	t. cruzi	GPE
dti-2024	113	11	pq	PERSON
dti-2024	113	12	qrs	PERSON
dti-2024	115	1	ecg	ORG
dti-2024	116	1	t. cruzi-infected mouse	PERSON
dti-2024	116	2	ecg	PRODUCT
dti-2024	116	3	2005	DATE
dti-2024	116	4	zaidenberg et al	PERSON
dti-2024	116	5	2006	DATE
dti-2024	117	1	2005	DATE
dti-2024	118	1	ecg	ORG
dti-2024	118	2	lo presti et al	PERSON
dti-2024	118	3	2004	DATE
dti-2024	118	4	al. 2005	GPE
dti-2024	118	5	garcia et al	PERSON
dti-2024	118	6	2005	DATE
dti-2024	118	7	zaidenberg et al	PERSON
dti-2024	118	8	2006	DATE
dti-2024	119	1	the infl amed	ORG
dti-2024	119	2	cd4+/cd8	ORG
dti-2024	119	3	0.37	CARDINAL
dti-2024	119	4	0.50	CARDINAL
dti-2024	120	1	68	CARDINAL
dti-2024	120	2	de souza	PERSON
dti-2024	120	3	2007	DATE
dti-2024	120	4	2	CARDINAL
dti-2024	120	5	cd4+/cd8	ORG
dti-2024	120	6	1997	DATE
dti-2024	120	7	marino et al	PERSON
dti-2024	120	8	2004	DATE
dti-2024	120	9	2005	DATE
dti-2024	120	10	2005	DATE
dti-2024	120	11	2006	DATE
dti-2024	121	1	ecg	PRODUCT
dti-2024	123	1	benznidazole	GPE
dti-2024	123	2	olivieri et al.	PERSON
dti-2024	123	3	2006	DATE
dti-2024	123	4	al. 2002	ORG
dti-2024	123	5	2004	DATE
dti-2024	124	1	t. cruzi	GPE
dti-2024	124	2	de souza et al	PERSON
dti-2024	124	3	2006b	DATE
dti-2024	124	4	infl	ORG
dti-2024	124	5	2000	DATE
dti-2024	124	6	2005	DATE
dti-2024	125	1	tarleton	GPE
dti-2024	125	2	2001	DATE
dti-2024	126	1	2006	DATE
dti-2024	127	1	t. cruzi	PERSON
dti-2024	127	2	infl	ORG
dti-2024	127	3	infl	ORG
dti-2024	127	4	dutra et al.	GPE
dti-2024	127	5	2005	DATE
dti-2024	128	1	ecg	ORG
dti-2024	128	2	1994	DATE
dti-2024	129	1	ccc	ORG
dti-2024	131	1	carlos chagas filho de amparo	PERSON
dti-2024	131	2	faperj	ORG
dti-2024	132	1	vinicius cottade-almeida	PERSON
dti-2024	132	2	lbc/ioc	ORG
dti-2024	133	1	david boykin	PERSON
dti-2024	133	2	georgia state university	ORG
dti-2024	133	3	atlanta	GPE
dti-2024	134	1	armenti, a. 2006	PERSON
dti-2024	138	1	144:724–34	CARDINAL
dti-2024	138	2	j.m.	GPE
dti-2024	138	3	rivarola	GPE
dti-2024	138	4	h.w.	GPE
dti-2024	139	1	r. et al	PERSON
dti-2024	139	2	2005	DATE
dti-2024	140	1	weekly	DATE
dti-2024	140	2	two	CARDINAL
dti-2024	142	1	j. cardiol	PERSON
dti-2024	142	2	102:211–7	CARDINAL
dti-2024	142	3	j.m.	GPE
dti-2024	142	4	rivarola	GPE
dti-2024	142	5	h.w.	GPE
dti-2024	143	1	a.r. et al	PERSON
dti-2024	143	2	2003	DATE
dti-2024	144	1	trypanosoma cruzi reinfections	ORG
dti-2024	146	1	103:136–42	DATE
dti-2024	146	2	coura	ORG
dti-2024	146	3	r.j.	PERSON
dti-2024	146	4	de castro	PERSON
dti-2024	146	5	s.l. 2002	ORG
dti-2024	148	1	oswaldo	PERSON
dti-2024	148	2	cruz	PERSON
dti-2024	150	1	dávila-spinetti	PERSON
dti-2024	150	2	d.f.	GPE
dti-2024	150	3	colmenarez-mendoza	PERSON
dti-2024	150	4	h.j.	GPE
dti-2024	150	5	lobo-vielma	PERSON
dti-2024	150	6	l. 2005	PERSON
dti-2024	154	1	cardiol	PERSON
dti-2024	154	2	58:1007–09	CARDINAL
dti-2024	155	1	de souza	PERSON
dti-2024	155	2	e.m.	GPE
dti-2024	155	3	a.	PERSON
dti-2024	155	4	c. et al	PERSON
dti-2024	155	5	2004	DATE
dti-2024	155	6	phenyl substitution	PERSON
dti-2024	155	7	trypanosoma cruzi	ORG
dti-2024	156	1	biochem	PERSON
dti-2024	157	1	pharmacol.	ORG
dti-2024	158	1	68:593–600	CARDINAL
dti-2024	159	1	de souza	PERSON
dti-2024	159	2	e.m.	GPE
dti-2024	159	3	oliveira	PERSON
dti-2024	159	4	g.m.	PERSON
dti-2024	159	5	boykin, d.w. et al. 2006a	ORG
dti-2024	159	6	trypanosoma cruzi	ORG
dti-2024	160	1	j. antimicrob	PERSON
dti-2024	161	1	de souza	PERSON
dti-2024	161	2	e.m.	GPE
dti-2024	161	3	menna-barreto	PERSON
dti-2024	161	4	r.	NORP
dti-2024	161	5	araujo-jorge	PERSON
dti-2024	161	6	2006b	DATE
dti-2024	163	1	g.a.	PERSON
dti-2024	163	2	freire-de-lima	PERSON
dti-2024	163	3	c.g.	GPE
dti-2024	163	4	m.p. et al.	PERSON
dti-2024	163	5	2005	DATE
dti-2024	165	1	21:237–43	CARDINAL
dti-2024	166	1	dutra	ORG
dti-2024	166	2	w.o.	GPE
dti-2024	166	3	rocha	PERSON
dti-2024	166	4	teixeira	GPE
dti-2024	166	5	m.m. 2005	PERSON
dti-2024	168	1	21:581–7	CARDINAL
dti-2024	168	2	cunha-neto	PERSON
dti-2024	168	3	kenneth	PERSON
dti-2024	168	4	2006	DATE
dti-2024	170	1	39:41–54	CARDINAL
dti-2024	170	2	69	CARDINAL
dti-2024	170	3	2007	DATE
dti-2024	170	4	2	CARDINAL
dti-2024	170	5	v.a.	GPE
dti-2024	170	6	bratton	GPE
dti-2024	170	7	d.l.	GPE
dti-2024	170	8	2000	DATE
dti-2024	172	1	405:85–90	DATE
dti-2024	173	1	c., higuchi	GPE
dti-2024	173	2	m.l.	GPE
dti-2024	173	3	carrasco	PERSON
dti-2024	173	4	h. et al.	PERSON
dti-2024	173	5	2005	DATE
dti-2024	174	1	t. cruzi	ORG
dti-2024	176	1	cardiol.	PERSON
dti-2024	177	1	garcia	PERSON
dti-2024	177	2	s.	PERSON
dti-2024	177	3	ramos	GPE
dti-2024	177	4	c.o.	GPE
dti-2024	177	5	j.f. et	GPE
dti-2024	179	1	antimicrob	PERSON
dti-2024	179	2	49:1521–8	TIME
dti-2024	180	1	golgher	PERSON
dti-2024	180	2	d.	NORP
dti-2024	180	3	r.t. 2004	PERSON
dti-2024	182	1	37:399–409	CARDINAL
dti-2024	182	2	olivieri	ORG
dti-2024	182	3	b.p	PERSON
dti-2024	182	4	oliveira	PERSON
dti-2024	182	5	g.m. et al	PERSON
dti-2024	182	6	2005	DATE
dti-2024	183	1	cd8(+	ORG
dti-2024	184	1	immun	PERSON
dti-2024	184	2	73:5048–52	CARDINAL
dti-2024	185	1	higuchi	GPE
dti-2024	185	2	m.d.	GPE
dti-2024	185	3	m.m.	PERSON
dti-2024	185	4	aiello	ORG
dti-2024	185	5	v.d. et al	PERSON
dti-2024	185	6	1997	DATE
dti-2024	186	1	trypanosoma cruzi	ORG
dti-2024	187	1	j. trop	PERSON
dti-2024	188	1	56:485–9	CARDINAL
dti-2024	189	1	a.f.	GPE
dti-2024	189	2	z.	PERSON
dti-2024	189	3	mishal	PERSON
dti-2024	189	4	l. et al	PERSON
dti-2024	189	5	2002	DATE
dti-2024	193	1	leon	PERSON
dti-2024	193	2	j.s.	PERSON
dti-2024	193	3	2003	DATE
dti-2024	195	1	biosci	GPE
dti-2024	197	1	lo presti	PERSON
dti-2024	197	2	m.s.	GPE
dti-2024	197	3	rivarola	GPE
dti-2024	197	4	h.w.	GPE
dti-2024	197	5	j.m. et	GPE
dti-2024	201	1	j. antimicrob	PERSON
dti-2024	201	2	23:634–6	CARDINAL
dti-2024	202	1	j.h.	GPE
dti-2024	202	2	hoff	GPE
dti-2024	202	3	r.	NORP
dti-2024	202	4	i. et al	PERSON
dti-2024	202	5	1987	DATE
dti-2024	203	1	brazilian	NORP
dti-2024	204	1	75:1140–5	CARDINAL
dti-2024	204	2	j.a.	GPE
dti-2024	204	3	simoes	PERSON
dti-2024	204	4	m.v.	GPE
dti-2024	204	5	sarabanda	GPE
dti-2024	204	6	1999	DATE
dti-2024	208	1	72:247–80	CARDINAL
dti-2024	209	1	marino	GPE
dti-2024	209	2	a.p.	GPE
dti-2024	209	3	da silva	PERSON
dti-2024	209	4	dos santos	PERSON
dti-2024	211	1	110:1443–9	DATE
dti-2024	212	1	m.n.	GPE
dti-2024	212	2	de souza	PERSON
dti-2024	212	3	w. 1982	PERSON
dti-2024	214	1	39:195–203	CARDINAL
dti-2024	215	1	olivieri	ORG
dti-2024	215	2	b.p.	GPE
dti-2024	215	3	araujo-jorge	PERSON
dti-2024	215	4	2002	DATE
dti-2024	216	1	benznidazole	GPE
dti-2024	217	1	antimicrob	PERSON
dti-2024	217	2	46:3790–6	CARDINAL
dti-2024	218	1	olivieri	ORG
dti-2024	218	2	b.p.	GPE
dti-2024	218	3	farias-de-oliveira	PERSON
dti-2024	218	4	d.a.	PERSON
dti-2024	218	5	araujo-jorge	PERSON
dti-2024	218	6	2005	DATE
dti-2024	219	1	benznidazole	DATE
dti-2024	220	1	antimicrob	PERSON
dti-2024	220	2	49:1981–7	CARDINAL
dti-2024	221	1	olivieri	ORG
dti-2024	221	2	b.p.	GPE
dti-2024	221	3	de souza	PERSON
dti-2024	221	4	a.p.	GPE
dti-2024	221	5	cotta-de-almeida	ORG
dti-2024	221	6	2006	DATE
dti-2024	222	1	cruzi	PERSON
dti-2024	224	1	114:228–34	CARDINAL
dti-2024	225	1	petkova	PERSON
dti-2024	225	2	s.b.	GPE
dti-2024	225	3	huang	PERSON
dti-2024	225	4	s.m. et	GPE
dti-2024	225	5	2001	DATE
dti-2024	228	1	j. parasitol.	PERSON
dti-2024	228	2	31	CARDINAL
dti-2024	228	3	499–511	CARDINAL
dti-2024	229	1	rivarola	GPE
dti-2024	229	2	h.w.	GPE
dti-2024	229	3	j.m.	GPE
dti-2024	230	1	lo presti	PERSON
dti-2024	230	2	s. et al.	PERSON
dti-2024	231	1	trypanosoma cruzi	ORG
dti-2024	233	1	rocha	PERSON
dti-2024	233	2	m.o.	GPE
dti-2024	233	3	ribeiro	PERSON
dti-2024	233	4	a.l.	GPE
dti-2024	233	5	teixeira	GPE
dti-2024	233	6	m.m.	PERSON
dti-2024	233	7	2003	DATE
dti-2024	235	1	biosci.	GPE
dti-2024	235	2	8:44–54	CARDINAL
dti-2024	236	1	romanha	ORG
dti-2024	236	2	a.j.	PERSON
dti-2024	236	3	alves	GPE
dti-2024	236	4	r.o.	GPE
dti-2024	236	5	murta	GPE
dti-2024	236	6	s.m. et	GPE
dti-2024	236	7	2002	DATE
dti-2024	237	1	trypanosoma cruzi	ORG
dti-2024	238	1	j. infect	PERSON
dti-2024	239	1	186:823–8	CARDINAL
dti-2024	240	1	s. and sousa	PERSON
dti-2024	240	2	a. et al	PERSON
dti-2024	240	3	2003	DATE
dti-2024	242	1	108:305–12	CARDINAL
dti-2024	243	1	soeiro	PERSON
dti-2024	243	2	m.n.	GPE
dti-2024	243	3	de souza	PERSON
dti-2024	243	4	e.m.	GPE
dti-2024	243	5	stephens	GPE
dti-2024	243	6	c.e. et al. 2005	GPE
dti-2024	245	1	opin	PERSON
dti-2024	246	1	investig	GPE
dti-2024	247	1	14:957–72	CARDINAL
dti-2024	248	1	tarleton	GPE
dti-2024	248	2	r.l. 2001	GPE
dti-2024	250	1	j. parasitol.	PERSON
dti-2024	250	2	31:550–4	CARDINAL
dti-2024	251	1	viotti	NORP
dti-2024	251	2	r.	NORP
dti-2024	251	3	h. et al	PERSON
dti-2024	252	1	1994.treatment	CARDINAL
dti-2024	254	1	j.	PERSON
dti-2024	254	2	127:151–62	DATE
dti-2024	254	3	viotti	NORP
dti-2024	254	4	r.	NORP
dti-2024	254	5	b. et al.	PERSON
dti-2024	254	6	2006	DATE
dti-2024	257	1	144:724–34	CARDINAL
dti-2024	258	1	werbovetz	PERSON
dti-2024	258	2	k. 2006	PERSON
dti-2024	259	1	antitrypanosomal	PERSON
dti-2024	260	1	curr	PERSON
dti-2024	261	1	opin	GPE
dti-2024	262	1	investig	GPE
dti-2024	264	1	7:147–57	DATE
dti-2024	264	2	wilson	ORG
dti-2024	264	3	w.d.	GPE
dti-2024	264	4	nguyen	PERSON
dti-2024	264	5	2005	DATE
dti-2024	266	1	curr	PERSON
dti-2024	267	1	5:389–408	CARDINAL
dti-2024	268	1	world health organization	ORG
dti-2024	269	1	2002	DATE
dti-2024	270	1	control of chagas disease	ORG
dti-2024	272	1	zaidenberg, a.	PERSON
dti-2024	272	2	luong	GPE
dti-2024	272	3	d. et al	PERSON
dti-2024	272	4	2006	DATE
dti-2024	273	1	uralin	PERSON
dti-2024	274	1	clin	PERSON
dti-2024	276	1	toxicol	TIME
dti-2024	276	2	98:351–6	CARDINAL
